Investment
Features
FeesSafety
Academy
More
Pluang+

Compare MNC Kapital Indonesia Tbk (BCAP) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance

MNC Kapital Indonesia Tbk
Brigit Biofarmaka Teknologi Tbk.

Price performance

Price movement over the last 24 hours

Key statistics

MNC Kapital Indonesia Tbk vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? MNC Kapital Indonesia Tbk trades at Rp50 (market cap 2.13T, 136K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp244 (market cap 164.65B, 214.9K 24h volume). The key difference: MNC Kapital Indonesia Tbk is far larger — about 12.9× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Brigit Biofarmaka Teknologi Tbk. is more actively traded (214.9K versus 136K). Which is the better fit depends on your goals.

BCAPOBAT
Market Cap
2.13T164.65B
Volume
136K214.9K
Lot
1.36K2.15K
Turnover
6.8M51.97M
Average Price
50241.85
Value
6.8M51.97M
Indicative Equilibrium Price
50240
Indicative Equilibrium Volume
1100

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

BCAP
View details
OBAT
View details

About MNC Kapital Indonesia Tbk

PT MNC Kapital Indonesia Tbk formerly PT Bhakti Capital Indonesia Tbk was established on 15 July 1999, resulting from the restructuring and consolidation of PT Bhakti Investama Tbk, its holding company. At the time it was established, the Company commenced its business activities in the securities sector, among others are financial advisory, brokerage, underwriting, and research and development. In 2003, the Company carried out a business consolidation and transformed into a holding company of several subsidiaries that are engaged in financial services sector, namely PT Bhakti Finance, PT Bhakti Securities, and PT Bhakti Asset Management.

Read more on BCAP

About Brigit Biofarmaka Teknologi Tbk.

PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.

Read more on OBAT